Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

M.Video-Eldorado on personal selection of premium home appliances

6/22/23 MVID

Shareholders of Rosseti Kuban approved dividends for 2022

6/22/23 KUBE

The Starbucks announced a quarterly dividend

6/22/23 SBUX

The HP announced a quarterly dividend

6/22/23 HPQ

Fesco organized air shipment of electronics from UAE to Russia

6/21/23 FESH

Shareholders of Rosseti Moscow Region approved dividends for 2022

6/21/23 MSRS

YandexLavka started selling food through vending machines

6/21/23 YNDX

Discount chain My Price reached 1,000 stores

6/21/23 MGNT

CarMoney goes on exchange

6/21/23 CARM

PhosAgro plans to increase supplies to Kazakhstan by 60%

6/21/23 PHOR